The Food and Drug Administration (FDA) has authorized another Covid-19 vaccine, developed by Moderna and federal researchers, to obtain such approval for emergency use in the US.
The emergency authorization of this vaccine to prevent Covid-19 for the American people brings another drug, and millions of doses are expected to begin immediate distribution to health workers and long-term care residents.
The modern vaccine is 94% effective in preventing Covid-19, and is authorized in people 18 and older. This authorization comes after being recommended by an FDA advisory panel of independent experts.
“Now with the availability of two vaccines for the prevention of Covid-1, the FDA has taken another decisive step in the fight against this global epidemic, which causes a large number of hospitalizations and deaths every day in the United States,” the FDA commissioner said in a statement. Declared a state of emergency.
The vaccine, developed by Modern and the National Institute of Allergy and Infectious Diseases (NIAID), uses messenger RNA technology to enter the body with spike proteins that cover the surface of the coronavirus.
“I expect to see a hand-shot early next week,” Dr. Anthony F. CA, director of the National Institute of Allergy and Infectious Diseases (NIAID), told NBC today.
Unlike the Pfizer vaccine, Moderna’s vaccine will be administered by the federal government, using funding from Operation Worm Speed, the Trump administration’s program to rapidly develop and disseminate Covid-19 vaccines and treatments.
Last week, the U.S. The first Pfizer vaccine to prevent the official Covid-19, using the same technique. Both companies are expected to apply for full approval for the vaccine in the coming months. Federal authorities expect to vaccinate 20 million people by the end of the year.
This authorization comes after the first dose of the vaccine developed by Pfizer was given to health workers and long-term care residents, after it was approved by the FDA last week.
Some high-profile individuals on Friday have already received the Pfizer vaccine, including Vice President Mike Pence and House Speaker Nancy Pelosi. Biden is scheduled to be vaccinated on Monday.
The modern vaccine has at least two distinct advantages over the first vaccine. It needs to be refrigerated, but does not need the ultra-cold-70C (-94F) required by Pfizer’s vaccine. This means that the vaccine may be easier to transport to rural areas, and less susceptible to spoilage. In addition, Moderna’s data show that its vaccine protects people against severe Covid-19, while it does not prevent the disease.
This authorization also comes at a time when the virus continues to pay a devastating toll on Americans. Thursday set a new record for daily deaths, with more than 500,500,000 people infected with the virus in a single day.
A commentary article published the same week in The Journal of the American Medical Association states: Were. Dr. Stephen Wolf and co-authors wrote that, or 15 Airbus 320 jetliners, each carrying 150 passengers, crash every day.
Authorization, a landmark achievement for modern medicine, is also a major achievement for Moderna. Prior to authorization, the company did not have any FDA-approved products. Prior to working on the mRNA vaccine for Covid-19, modern-day scientists were primarily researching mRNA technology in cancer.
The Moderna vaccine brings the number of potential doses to as many as 100,000 million, with the risk being high among high-risk individuals, with 200 million Moderna contracted to provide to the federal government.
Because each vaccine requires a two-dose “booster” method, it means that U.S. There will be enough doses to vaccinate 150 million people in, if it is able to effectively roll out an ambitious vaccination campaign in the history of medicine. Moderna relies primarily on subcontractors to produce millions of doses of its vaccine.
Despite the great achievement of authorizing another vaccine, scientists will still need to move on to more vaccine candidates, to provide a productive capacity to reach millions of other Americans and people around the world.
This means that authorization for a second vaccine will not immediately return to normal, as it will take a better year to vaccinate and distribute to millions of Americans.
Both shots will need to remove the high level of vaccine hesitation from the skeptical and boring American public, who have been bombing with false information for months. The Moderna vaccine may also pose a further hurdle, the same White House that played a role in the development of the Covid-19 misinformation.
In a trial of more than 30,000 patients, Moder’s vaccine was found to be more than 94% effective in preventing Covid-19. Modern scientists say his trial has two allergic reactions, one in the placebo hand and the other in the vaccinator.
At the hands of the vaccine, the allergic reaction was 60 days after the participant received the vaccine, and was found to be related to a different medical procedure.
